Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Changzhou Institute Of Technology maintains a patent portfolio focused on the Biotechnology & Pharmaceuticals technology area. The data shows 1 pending office action currently active for the organization. This activity is restricted to 1 distinct art unit, reflecting a narrow technical scope in its current patenting efforts. Such a focused distribution indicates that the institute is prioritizing a specific innovation within the Biotechnology & Pharmaceuticals sector.
The prosecution is being handled by 1 distinct examiner. THOMAS, TIMOTHY P is the busiest examiner for this portfolio, handling 1 pending office action. This indicates that all current interactions with the patent office are channeled through this official. The use of 1 distinct examiner suggests a centralized review process, which simplifies the communication path but also concentrates the prosecution risk.
For patent practitioners, the presence of 1 pending office action in 1 distinct art unit suggests a streamlined but singular prosecution path. Since THOMAS, TIMOTHY P handles 1 pending office action, the outcome of the current portfolio activity depends entirely on the requirements of this specific official. This profile reflects an intellectual property strategy that relies on navigating the interpretation of the assigned examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMAS, TIMOTHY P | 1 | 26.3% | +38.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17781006 | HIGH-STRENGTH MEDICAL FIBER COMPOSITE MATERIAL | THOMAS, TIMOTHY P | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17781006 | HIGH-STRENGTH MEDICAL FIBER COMPOSITE MATERIAL | THOMAS, TIMOTHY P | 17d overdue |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17781006 | HIGH-STRENGTH MEDICAL FIBER COMPOSITE MATERIAL | THOMAS, TIMOTHY P | 1614 | §103 | Non-Final OA | 17d overdue | Pending | May 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial